BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 3518963)

  • 81. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Antibacterial activity of cephem antibiotics against isolates from clinical specimens at the Yokohama City University Hospital].
    Kaminaga Y; Sato Y; Hanada K; Ito A
    Jpn J Antibiot; 1986 Oct; 39(10):2547-56. PubMed ID: 3543429
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cefamandole: antimicrobial activity in vitro of a new cephalosporin.
    Meyers BR; Leng B; Hirschman SZ
    Antimicrob Agents Chemother; 1975 Dec; 8(6):737-41. PubMed ID: 1044248
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vitro activity of cefotaxime against clinically significant pathogens.
    Nakashio S; Nakamura M
    Drugs; 1988; 35 Suppl 2():14-21. PubMed ID: 3260852
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Kuriyama T; Karasawa T; Nakagawa K; Nakamura S; Yamamoto E
    Oral Microbiol Immunol; 2002 Oct; 17(5):285-9. PubMed ID: 12354209
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Frequency of in vitro sensitivity to netilmicin and ceftizoxime on selected highly resistant flora in surgical intensive therapy].
    Pessione E; Alberghina A; Franchello A; Verna C; Olivero G
    Minerva Med; 1988 Feb; 79(2):133-6. PubMed ID: 3162558
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
    Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cefmetazole (CS-1170): a new cephamycin with activity against gram-negative bacilli and staphylococci.
    Benlloch M; Torres A; Soriano F
    J Antimicrob Chemother; 1982 Oct; 10(4):347-50. PubMed ID: 6958672
    [No Abstract]   [Full Text] [Related]  

  • 91. Antibacterial activity of five cephalosporins.
    Mutton KJ; Harkness JL
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.
    Inouye S; Goi H; Watanabe T; Hara T; Miyauchi K; Yoshida T; Kazuno Y; Kadosawa H; Hirano F; Kawaharajo K
    Antimicrob Agents Chemother; 1984 Nov; 26(5):722-9. PubMed ID: 6440478
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [TBL] [Abstract][Full Text] [Related]  

  • 94. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Comparison of the antibacterial efficacy of doxycycline and tetracycline (author's transl)].
    Semenitz E; Lackner M
    Med Klin; 1977 Feb; Spec No():suppl 12-6. PubMed ID: 320436
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In vitro antimicrobial activity of ceftizoxime.
    Schell RF; LeFrock JL; Smith BR; Francisco M
    Chemotherapy; 1983; 29(6):408-14. PubMed ID: 6317295
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In-vitro activity of cefoxitin against recent clinical bacterial isolates.
    MacCulloch D; Cornere BM
    N Z Med J; 1979 Feb; 89(629):83-5. PubMed ID: 286213
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ceftizoxime (FK 749) in vitro antibacterial activity.
    Husson MO; Courcol R; Izard D; Leclerc H
    Infection; 1984; 12(1):40-5. PubMed ID: 6323320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.